Trial Profile

Phase II Trial of Low-Dose Methotrexate and Iodine I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 04 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Iodine-131 tositumomab (Primary) ; Methotrexate
Indications Follicular lymphoma
Focus Adverse reactions

Most Recent Events

20 Jun 2016 Status changed from suspended to discontinued as Bexxar isn't being produced by the manufacturer as of Feb. 2014
03 Oct 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.
04 Jun 2013 15 patients were enrolled between August 2011 and October 2012, according to ASCO 2013 abstract.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com